Physician profile
Daniel Goldstein
NPI 1750542270
$3,348.50
in general payments reported to CMS, 2019-2025
21 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,103 · 2020: $50.99 · 2021: $1,006 · 2022: $85.06 · 2023: $433 · 2024: $394 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $880.43 | 2019-2022 | |
| Depuy Synthes Sales INC. | $602.73 | 2019-2024 | Orthovisc |
| Stryker Corporation | $323.36 | 2019-2025 | Triathlon, System 9 Cd Nxt |
| Globus Medical, INC. | $216.65 | 2022-2023 | Providence, Tibial Nail |
| Zimmer Biomet Holdings, INC. | $208.24 | 2022-2025 | Gel-One Cross-Linked Hyaluronate |
| Smith+Nephew, INC. | $176.18 | 2019-2025 | Real Intelligence |
| Abiomed | $126.05 | 2024 | Impella |
| Medical Device Business Services, INC. | $116.85 | 2019-2021 | |
| Pacira Therapeutics, INC. | $108.26 | 2019-2021 | |
| Heraeus Medical, LLC. | $106.81 | 2023-2025 | Palacos |
| Orthalign INC | $92.70 | 2024 | Orthalign Plus |
| Ferring Pharmaceuticals INC. | $76.41 | 2019-2025 | Euflexxa |
| Dynasplint Systems INC. | $70.42 | 2024 | Dynasplint |
| Fidia Pharma USA INC. | $53.60 | 2019 | |
| Ethicon US, LLC | $52.57 | 2021-2023 | Stratafix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $47.41 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.60 | 2023 | Iovera, Zilretta, Exparel |
| Solventum Corporation | $19.48 | 2025 | Prevena, V.A.C.Ulta |
| Baxter Healthcare | $17.13 | 2025 | Tisseel |
| Medtronic, INC. | $14.94 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.